Differential safety profiles of disease-modifying therapies in MS: Age- and sex-based analysis from a real-world cohort. Ercan M C, Cakan E, Gumus Y, Ozen N P A, Tuncer A, Karabudak R Mult Scler Relat Disord. 2026 Apr 30; 111:107220. PMID: 42107470. Abstract CommentRecommendBookmarkWatch
